Jump to content

Wikipedia:WikiProject Chemicals/Chembox validation/VerifiedDataSandbox and Pipobroman: Difference between pages

(Difference between pages)
Page 1
Page 2
Content deleted Content added
Saving copy of the {{drugbox}} taken from revid 447585415 of page Pipobroman for the Chem/Drugbox validation project (updated: 'DrugBank').
 
m combined the 2 sentences as one of them was too small
 
Line 1: Line 1:
{{Short description|Chemical compound}}
{{ambox | text = This page contains a copy of the infobox ({{tl|drugbox}}) taken from revid [{{fullurl:Pipobroman|oldid=447585415}} 447585415] of page [[Pipobroman]] with values updated to verified values.}}
{{Drugbox
{{Drugbox
| verifiedrevid = 411550519
| verifiedrevid = 464207677
| IUPAC_name = 3-bromo-1-[4-(3-bromopropanoyl) piperazin-1-yl]-propan-1-one
| IUPAC_name = 3-bromo-1-[4-(3-bromopropanoyl) piperazin-1-yl]-propan-1-one
| image = Pipobroman.svg
| image = Pipobroman.svg

<!--Clinical data-->
<!--Clinical data-->
| tradename =
| tradename = Vercite, Vercyte
| Drugs.com = {{drugs.com|international|pipobroman}}
| Drugs.com = {{drugs.com|international|pipobroman}}
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
Line 16: Line 15:
| legal_status =
| legal_status =
| routes_of_administration =
| routes_of_administration =

<!--Pharmacokinetic data-->
<!--Pharmacokinetic data-->
| bioavailability =
| bioavailability =
Line 23: Line 21:
| elimination_half-life =
| elimination_half-life =
| excretion =
| excretion =

<!--Identifiers-->
<!--Identifiers-->
| IUPHAR_ligand = 7271
| CASNo_Ref = {{cascite|correct|CAS}}
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 54-91-1
| CAS_number = 54-91-1
| ATC_prefix = L01
| ATC_prefix = L01
Line 39: Line 37:
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D00467
| KEGG = D00467
| ChEBI = 8242
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 1585
| ChEMBL = 1585

<!--Chemical data-->
<!--Chemical data-->
| C=10 | H=16 | Br=2 | N=2 | O=2
| C=10 | H=16 | Br=2 | N=2 | O=2
| molecular_weight = 356.054 g/mol
| smiles = O=C(N1CCN(C(=O)CCBr)CC1)CCBr
| smiles = O=C(N1CCN(C(=O)CCBr)CC1)CCBr
| InChI = 1/C10H16Br2N2O2/c11-3-1-9(15)13-5-7-14(8-6-13)10(16)2-4-12/h1-8H2
| InChIKey = NJBFOOCLYDNZJN-UHFFFAOYAD
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C10H16Br2N2O2/c11-3-1-9(15)13-5-7-14(8-6-13)10(16)2-4-12/h1-8H2
| StdInChI = 1S/C10H16Br2N2O2/c11-3-1-9(15)13-5-7-14(8-6-13)10(16)2-4-12/h1-8H2
Line 53: Line 48:
| StdInChIKey = NJBFOOCLYDNZJN-UHFFFAOYSA-N
| StdInChIKey = NJBFOOCLYDNZJN-UHFFFAOYSA-N
}}
}}
'''Pipobroman''' (trade names '''Vercite''', '''Vercyte''') is an anti-cancer drug that probably acts as an [[alkylating antineoplastic agent|alkylating agent]],<ref>{{cite journal | vauthors = Passamonti F, Lazzarino M | title = Treatment of polycythemia vera and essential thrombocythemia: the role of pipobroman | journal = Leukemia & Lymphoma | volume = 44 | issue = 9 | pages = 1483–8 | date = September 2003 | pmid = 14565648 | doi = 10.3109/10428190309178768 }}</ref> and is marketed in France and Italy.<ref>{{cite web | work = Drugs.com | url = https://www.drugs.com/international/pipobroman.html | title = Pipobroman }}</ref>

== References ==
{{reflist}}

{{Chemotherapeutic agents}}

[[Category:Alkylating antineoplastic agents]]
[[Category:Organobromides]]
[[Category:Carboxamides]]
[[Category:Piperazines]]

{{antineoplastic-drug-stub}}